Management of Adverse Events Associated With Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Leukemia - United Kingdom
doi 10.1038/leu.2010.215
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC